Early trials suggest the combination of these two hormones has an additive effect on appetite suppression and weight reduction , making CagriSema a major contender in the future of obesity treatment
FDA approval Both medications are approved by the U.S
10.1002/elps.200600022 52 Vilar NetoJ
*Serving women in-person in Omaha, Nebraska A Different Kind of Weight Loss Care Weight management isn't about willpower or disciplineit's about biology, hormones, and finding the right tools that work with your unique body, not against it
Calendar reminders help until the habit solidifies
Comprehensive safety analysis across over 11,000 participants found that serious adverse events were uncommon, and in cardiovascular outcome trials, serious adverse events were actually lower with semaglutide versus placebo